Syngene International Q1 FY27 Results: Share Price Hit 52-Week Low

Syngene International share price declined more than 9% in early trade on July 30, 2026, after the company reported a net loss for the quarter ended June 30, 2026 (Q1 FY27). The weak quarterly performance and lower revenue weighed on investor sentiment, pushing the stock to a 52-week low.
The stock opened at ₹391 on the NSE and fell to an intraday low of ₹375.25. At around 9:30 AM, it was trading nearly 8.8% lower at ₹377.80, with around 2 million shares changing hands.
Syngene InternationalQ1 FY27 Financial Performance
Syngene International reported a consolidated net loss of ₹9 crore in the first quarter of FY27, compared with a net profit of ₹86.7 crore in the same quarter last year.
Revenue from operations also declined to ₹736 crore, down from ₹874.5 crore in the corresponding quarter of the previous financial year.
The company's total expenses stood at ₹767 crore, compared with ₹790.9 crore in Q1 FY26.
Why Did the Company Report Loss?
According to the company, its quarterly earnings were affected by:
- Lower revenue during the quarter
- Employee separation costs
- An exceptional expense of ₹13.5 crore related to termination benefits
These factors together resulted in the company reporting a quarterly loss despite a reduction in overall expenses.
Syngene International Share Price Movement
As of July 30, 2026, 11:08 AM, Syngene International share price (NSE: SYNGENE) was trading at ₹392.65, down ₹21.60 or 5.21% for the day. The stock opened at ₹391.00, touched an intraday high of ₹397.40, and fell to a 52-week low of ₹375.25 during the session.
Read More: Best Gold Stocks in July 2026 Based on 5‑Year CAGR: Sky Gold and Diamonds, Laxmi Goldorna House and More!
Conclusion
Syngene International's disappointing Q1 FY27 results, including a ₹9 crore net loss and weaker revenue, led to a sharp decline in its share price.
For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Turn insights into action - Open Free Demat Account with Angel One and start investing instantly.
Published on: Jul 30, 2026, 11:39 AM IST

Kusum Kumari
Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.
Know More- Sugar Stocks Rally; Shree Renuka Sugars, Bajaj Hindusthan, and Others Surge Up To 12% on August 24, 2026
- Piramal Finance Share Price in Focus; Approves ₹1,750 Crore Warrant Issue to Nithyam Realty
- Aurobindo Pharma Share Price in Focus; US FDA Completes Inspection at Lannett Company LLC
- JTL Industries Share Price in Focus; Subsidiary to Double Narrow-Width HR Coil Capacity
- Caplin Point Laboratories Shares in Focus; Announces Completion of Unannounced US FDA Inspection at Facility


